Dr. Aloia serves as executive vice president and system chief clinical officer of Ascension, leading clinical strategy, quality, safety, care transformation and physician engagement across one of the nation’s largest nonprofit health systems. He oversees clinical performance across more than 2,600 sites of care, aligning primary care redesign, specialty integration, virtual care and service line strategy with Ascension’s value-based care goals. Through executive sponsorship of the system’s clinical innovation institute and oversight of the Ascension Clinical Research Institute, he has built an enterprise infrastructure that integrates research, analytics and digital tools directly into clinical workflows. Ascension now supports nearly 3,000 active or approved research studies within a unified clinical trials management platform designed to accelerate evidence translation into frontline practice. Under his leadership, the system has advanced scalable care models aimed at improving coordination, reducing unnecessary acute utilization and strengthening clinician experience. A hepatobiliary surgical oncologist and former chief quality officer at Houston-based MD Anderson Cancer Center, Dr. Aloia brings academic rigor to enterprise operations while positioning innovation as a driver of measurable gains in access, affordability and outcomes across Ascension.
